Federal Reserve Chair Jerome Powell told lawmakers on Tuesday the argument for free trade still makes sense but added that it was not the role of the central bank to comment on tariff or trade policy ...
Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.
I’ve seen significant improvements over the past couple of years,” said Reece Bell, who normally commutes on BART to work ...
With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...
CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...
Radiation dose intensification improves pathologic complete response rates in locally advanced rectal cancer but also leads ...
Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...
Better access and capability scores were associated with integrated practice ownership and participation in accountable care ...
In what’s been a common theme through economic headwinds, the franchising sector in 2024 outperformed expectations for the ...
A police force has to make improvements, including its reaction time to emergency calls, a report has said. In a recent ...
Tislelizumab plus low-dose nab-paclitaxel “demonstrated enduring efficacy while maintaining a manageable safety profile,” according to researchers.
The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer are eligible for T-DXd treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback